Triethylamine → HCID 58109221, compound
Reaction equation
[NH2:1][CH2:2][CH2:3][CH2:4][C@@:5]1([C:20]2[CH:25]=[CH:24][C:23]([F:26])=[CH:22][CH:21]=2)[O:10][C:9](=[O:11])[N:8]([C@H:12]([CH:14]2[CH2:19][CH2:18][CH2:17][CH2:16][CH2:15]2)[CH3:13])[CH2:7][CH2:6]1.CCN(CC)CC.[CH3:34][S:35](Cl)(=[O:37])=[O:36]>>[CH:14]1([C@@H:12]([N:8]2[CH2:7][CH2:6][C@:5]([CH2:4][CH2:3][CH2:2][NH:1][S:35]([CH3:34])(=[O:37])=[O:36])([C:20]3[CH:25]=[CH:24][C:23]([F:26])=[CH:22][CH:21]=3)[O:10][C:9]2=[O:11])[CH3:13])[CH2:19][CH2:18][CH2:17][CH2:16][CH2:15]1Participants
Procedure
To a solution of (R)-6-(3-aminopropyl)-3-((S)-1-cyclohexylethyl)-6-(4-fluorophenyl)-1,3-oxazinan-2-one (30 mg, 0.10 mmol) was added Et3N (40 mg, 0.4 mmol) and MsCl (30 mg, 0.24 mmol) at 0° C. The reaction solution was stirred at rt for 2 h. The reaction was quenched by H2O and the mixture was extracted with CH2Cl2. The organic phase was concentrated to give the crude product, which was purified by preparative TLC to give N-(3-((R)-3-((S)-1-cyclohexylethyl)-6-(4-fluorophenyl)-2-oxo-1,3-oxazinan-6-yl)propyl)methanesulfonamide (11.5 mg, 33%). LC-MS Method 2 tR=1.397 min, m/z=440.9; 1H NMR (CDCl3) 1.04 (d, 6H), 1.13-1.34 (m, 2H), 1.43-1.68 (m, 6H), 1.73-1.98 (m, 3H), 2.03-2.14 (m, 1H), 2.29 (d, 1H), 2.52 (tt, 1H), 2.85 (s, 3H), 2.92-3.08 (m, 3H), 3.68 (m, 1H), 3.88-3.98 (m, 1H), 4.33 (t, 1H), 7.01 (t, 2H), 7.22 (m, 2H).
Workup
- customThe reaction was quenched by H2O
- extractionthe mixture was extracted with CH2Cl2
- concentrationThe organic phase was concentrated
- customto give the crude product, which
- customwas purified by preparative TLC
Sources & evidence
- ORD record
- ord-99f77b58d4ac4b69992f2b5c8774ac3a
- Source dataset
- uspto-grants-2013_11
- Patent number
- US08575156B2
Reaction notes
Loading…